In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received the United States Food & Drug Administration (USFDA) approval for Gabapentin Tablets USP, 600 mg and 800 mg. This approval marks a significant milestone for Strides, […]
Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for once-daily Gabapentin Tablets, 300 mg and 600 mg from the US Food and Drug Administration (FDA). The approved product is the generic of Gralise Tablets, which are used for managing postherpetic neuralgia (PHN). As per IQVIA MAT December 2022, the annual […]
